Ipca Laboratories has reported results for the year ended March 31, 2011.
The company has posted a net profit of Rs 255.37 crore for FY11, up by 22.08% as compared to Rs 209.19 crore in the last year. Total income has increased by 21.15% to Rs 1881.10 crore for the year under review from Rs 1552.74 crore in previous year.
On consolidated basis, the net profit has rose by 27.98% at Rs 262.82 crore for FY11 as compared to Rs 205.36 crore for FY10. Its total income has increased by 21.20% to Rs 1898.86 crore for the year under review from Rs 1566.76 crore a period ago.
Ipca Laboratories has recommended a final dividend of Rs 1.20 per share or 60% for the financial year ended March 31, 2011.
